TTD | Drug: D0F1IS

Drug General Information
Drug ID	D0F1IS
Former ID	DNC005203
Drug Name	BMS-189323
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[527291]
Structure		Download 2D MOL 3D MOL
Formula	C32H41N5O6
Canonical SMILES	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC(=CC=C2)NC(=O)NCCCN3CCN(<br />CC3)C4=CC=CC=C4OC)C(=O)OC
InChI	1S/C32H41N5O6/c1-21-27(30(38)42-4)29(28(22(2)34-21)31(39)43-5)23-10-8-11-24(20-23)35-32(40)33-14-9-15-36-16-18-37(19-17-36)25-12-6-7-13-26(25)41-3/h6-8,10-13,20,29,34H,9,14-19H2,1-5H3,(H2,33,35,40)
InChIKey	HSUYTMPXLKOBTD-UHFFFAOYSA-N
PubChem Compound ID	11548842
Target and Pathway
Target(s)	Neuropeptide Y receptor type 1	Target Info	Inhibitor	[527291]
KEGG Pathway	cAMP signaling pathway
KEGG Pathway	Neuroactive ligand-receptor interaction
NetPath Pathway	FSH Signaling Pathway
Reactome	Peptide ligand-binding receptors
Reactome	G alpha (i) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Peptide GPCRs
	Endothelin Pathways
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 527291	Bioorg Med Chem Lett. 2004 Dec 20;14(24):5975-8.Isosteric N-arylpiperazine replacements in a series of dihydropyridine NPY1 receptor antagonists.
Ref 527291	Bioorg Med Chem Lett. 2004 Dec 20;14(24):5975-8.Isosteric N-arylpiperazine replacements in a series of dihydropyridine NPY1 receptor antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information